A systems approach to identifying the challenges of implementing deprescribing in older adults across different health-care settings and countries: a narrative review

References

• World Health Organization. Global Patient Safety Challenge on Medication Safety; 2017 [cited 2020 Jan 28]. Available from: https://apps.who.int/iris/bitstream/handle/10665/255263/WHO-HIS-SDS-2017.6-eng.pdf;jsessionid=ABAC16CD211D1397F08BCA9BEC7E6C1E?sequence=1
   Google Scholar
• Scott IA, Guyatt GH. Cautionary tales in the interpretation of clinical studies involving older persons interpretation of clinical studies. JAMA Intern Med. 2010;170(7):587–595.
   Google Scholar
• Hedna K, Hakkarainen KM, Gyllensten H, et al. Potentially inappropriate prescribing and adverse drug reactions in the elderly: a population-based study. Eur J Clin Pharmacol. 2015;71(12):1525–1533.
   PubMed Web of Science ®Google Scholar
• Page AT, Clifford RM, Potter K, et al. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. British J Clin. 2016;82(3):583–623.
   PubMed Web of Science ®Google Scholar
• National Academy of Engineering and Institute of Medicine Committee on Engineering and the Health Care System. Building a better delivery system: a new engineering/health care partnership. Reid PP, Compton WD, Grossman JH. et al., editors. Washington (DC): National Academies Press (US); 2005
   Google Scholar
• Reeve E, Gnjidic D, Long J, et al. A systematic review of the emerging definition of ‘deprescribing’ with network analysis: implications for future research and clinical practice. Br J Clin. 2015;80(6):1254–1268.
   Google Scholar
• Scott IA, Hilmer SN, Reeve E, et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015;175(5):827–834.
   PubMed Web of Science ®Google Scholar
• Anderson K, Stowasser D, Freeman C, et al. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.
   PubMed Web of Science ®Google Scholar
• Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33(4):323–328.
   Google Scholar
• World Health Organization. Dementia: a public health priority; 2012 [cited2020 Jan 28]. Available from: http://www.who.int/mental_health/publications/dementia_report_2012/en/
   Google Scholar
• Page AT, Falster MO, Litchfield M, et al. Polypharmacy among older Australians, 2006–2017: a population-based study. Med J Aust. 2019;211:71–75.
   Web of Science ®Google Scholar
• Guthrie B, Makubate B, Hernandez-Santiago V, et al. The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010. BMC Med. 2015;13:74.
   PubMed Web of Science ®Google Scholar
• LOWN Institute. Medication overload: America’s other drug problem. How the drive to prescribe is harming older adults: LOWN Institute; 2019 [cited2020 Jan 28]. Available from: https://lowninstitute.org/medication-overload-how-the-drive-to-prescribe-is-harming-older-americans/
   Google Scholar
• Opondo D, Eslami S, Visscher S, et al. Inappropriateness of medication prescriptions to elderly patients in the primary care setting: a systematic review. PLoS One. 2012;7(8):e43617.
   PubMed Web of Science ®Google Scholar
• Morin L, Laroche ML, Texier G, et al. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. J Am Med Dir Assoc. 2016;17(9):862.e1–862.e9.
   PubMed Web of Science ®Google Scholar
• Redston MR, Hilmer SN, McLachlan AJ, et al. Prevalence of potentially inappropriate medication use in older inpatients with and without cognitive impairment: a systematic review. J Alzheimers Dis. 2018;61(4):1639–1652.
   PubMed Web of Science ®Google Scholar
• Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13(1):57–65.
   PubMed Web of Science ®Google Scholar
• Boghossian TA, Rashid FJ, Thompson W, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017;3:Cd011969.
   PubMedGoogle Scholar
• Van Leeuwen E, Petrovic M, van Driel ML, et al. Withdrawal versus continuation of long-term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev. 2018;3:Cd007726.
   PubMedGoogle Scholar
• Reeve E, Ong M, Wu A, et al. A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. Eur J Clin Pharmacol. 2017;73(8):927–935.
   PubMed Web of Science ®Google Scholar
• Beuscart J-B, Knol W, Cullinan S, et al. International core outcome set for clinical trials of medication review in multi-morbid older patients with polypharmacy. BMC Med. 2018;16(1):21.
   PubMedGoogle Scholar
• McGrattan M, Barry HE, Ryan C, et al. The development of a core outcome set for medicines management interventions for people with dementia in primary care. Age Ageing. 2019;48(2):260–266.
   PubMed Web of Science ®Google Scholar
• Moore GF, Audrey S, Barker M, et al. Process evaluation of complex interventions: medical research council guidance. BMJ. 2015;350;h1258.
   Google Scholar
• Gnjidic D, Le Couteur DG, Kouladjian L, et al. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med. 2012;28(2):237–253.
   PubMed Web of Science ®Google Scholar
• Westbury J, Tichelaar L, Peterson G, et al. A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. Int Psychogeriatr. 2011;23(8):1260–1269.
   PubMed Web of Science ®Google Scholar
• Gerritsen DL, de Vries E, Smalbrugge M, et al. Implementing a multidisciplinary psychotropic medication review among nursing home residents with dementia: a process evaluation. Int Psychogeriatr. 2019;1–13.
   PubMedGoogle Scholar
• Reeve E, To J, Hendrix I, et al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging. 2013;30(10):793–807.
   PubMed Web of Science ®Google Scholar
• Dills H, Shah K, Messinger-Rapport B, et al. Deprescribing medications for chronic diseases management in primary care settings: a systematic review of randomized controlled trials. J Am Med Dir Assoc. 2018;19(11):923–935.e2.
   PubMed Web of Science ®Google Scholar
• Ailabouni NJ, Nishtala PS, Mangin D, et al. Challenges and enablers of deprescribing: a general practitioner perspective. PLoS One. 2016;11(4):e0151066.
   PubMed Web of Science ®Google Scholar
• L OD E, Sullivan K, McKenna H. The rising cost of medicines to the NHS. What’s the story? King’s Fund, editor. 2018.
   Google Scholar
• Sinnott C, Hugh SM, Boyce MB, et al. What to give the patient who has everything? A qualitative study of prescribing for multimorbidity in primary care. Br J Gen Pract. 2015;65(632):e184–e191.
   PubMed Web of Science ®Google Scholar
• Gillespie RJ, Harrison L, Mullan J. Deprescribing medications for older adults in the primary care context: a mixed studies review. Health Sci Rep. 2018;1(7):e45.
   PubMedGoogle Scholar
• Scott IA, Pillans PI, Barras M, et al. Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Ther Adv Drug Saf. 2018;9(9):559–573.
   PubMed Web of Science ®Google Scholar
• Bokhof B, Junius-Walker U. Reducing polypharmacy from the perspectives of general practitioners and older patients: a synthesis of qualitative studies. Drugs Aging. 2016;33(4):249–266.
   PubMed Web of Science ®Google Scholar
• Reeve E, Wolff JL, Skehan M, et al. Assessment of attitudes toward deprescribing in older medicare beneficiaries in the United States. JAMA Intern Med. 2018;178(12):1673–1680.
   PubMed Web of Science ®Google Scholar
• Hoisnard L, Santos-Eggimann B, Chauvin P, et al. Do older adults know the purpose of their medications? A survey among community-dwelling people. Eur J Clin Pharmacol. 2019;75(2):255–263.
   PubMed Web of Science ®Google Scholar
• Linsky A, Simon SR, Bokhour B. Patient perceptions of proactive medication discontinuation. Patient Educ Couns. 2015;98(2):220–225.
   PubMed Web of Science ®Google Scholar
• Reeve E, Low LF, Hilmer SN. Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. Br J Gen Pract. 2016;66(649):e552–e560.
   PubMed Web of Science ®Google Scholar
• Turner JP, Tannenbaum C. Older adults’ awareness of deprescribing: a population-based survey. J Am Geriatr Soc. 2017;65(12):2691–2696.
   PubMed Web of Science ®Google Scholar
• Todd A, Jansen J, Colvin J, et al. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. BMC Geriatr. 2018;18(1):295.
   PubMedGoogle Scholar
• Kouladjian L, Gnjidic D, Reeve E, et al. Health care practitioners’ perspectives on deprescribing anticholinergic and sedative medications in older adults. Ann Pharmacother. 2016;50(8):625–636.
   PubMed Web of Science ®Google Scholar
• Clyne B, Cooper JA, Hughes CM, et al. ‘Potentially inappropriate or specifically appropriate?’ Qualitative evaluation of general practitioners views on prescribing, polypharmacy and potentially inappropriate prescribing in older people [journal article]. BMC Fam Pract. 2016;17(1):109.
   PubMedGoogle Scholar
• Hubbard RE, Peel NM, Scott IA, et al. Polypharmacy among inpatients aged 70 years or older in Australia. Med J Aust. 2015;202(7):373–377.
   PubMed Web of Science ®Google Scholar
• Ni Chroinin D, Neto HM, Xiao D, et al. Potentially inappropriate medications (PIMs) in older hospital in-patients: prevalence, contribution to hospital admission and documentation of rationale for continuation. Australas J Ageing. 2016;35(4):262–265.
   PubMed Web of Science ®Google Scholar
• Todd A, Al-Khafaji J, Akhter N, et al. Missed opportunities: unnecessary medicine use in patients with lung cancer at the end of life – an international cohort study. Br J Clin Pharmacol. 2018;84(12):2802–2810.
   PubMed Web of Science ®Google Scholar
• Scott S, Clark A, Farrow C, et al. Deprescribing admission medication at a UK teaching hospital; a report on quantity and nature of activity. Int J Clin Pharm. 2018;40(5):991–996.
   PubMed Web of Science ®Google Scholar
• Cullinan S, Fleming A, O’Mahony D, et al. Doctors’ perspectives on the barriers to appropriate prescribing in older hospitalized patients: a qualitative study. Br J Clin Pharmacol. 2015;79(5):860–869.
   PubMed Web of Science ®Google Scholar
• Jubraj B, Marvin V, Poots AJ, et al. A pilot survey of junior doctors’ attitudes and awareness around medication review: time to change our educational approach? Eur J Hosp Pharm Sci Pract. 2015;22(4):243–248.
   PubMedGoogle Scholar
• Viktil KK, Blix HS, Eek AK, et al. How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2012;2(6):e001461.
   PubMed Web of Science ®Google Scholar
• Scott IA, Le Couteur DG. Physicians need to take the lead in deprescribing. Intern Med J. 2015;45(3):352–356.
   PubMed Web of Science ®Google Scholar
• Cheema E, Alhomoud FK, Kinsara ASA, et al. The impact of pharmacists-led medicines reconciliation on healthcare outcomes in secondary care: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2018;13(3):e0193510.
   PubMed Web of Science ®Google Scholar
• Dalton K, O’Brien G, O’Mahony D, et al. Computerised interventions designed to reduce potentially inappropriate prescribing in hospitalised older adults: a systematic review and meta-analysis. Age Ageing. 2018;47(5):670–678.
   PubMed Web of Science ®Google Scholar
• Thillainadesan J, Gnjidic D, Green S, et al. Impact of deprescribing interventions in older hospitalised patients on prescribing and clinical outcomes: a systematic review of randomised trials [journal article]. Drugs Aging. 2018;35(4):303–319.
   PubMed Web of Science ®Google Scholar
• Qi K, Reeve E, Hilmer SN, et al. Older peoples’ attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. Int J Clin Pharm. 2015;37(5):949–957.
   PubMed Web of Science ®Google Scholar
• Galazzi A, Lusignani M, Chiarelli MT, et al. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. Int J Clin Pharm. 2016;38(2):454–461.
   PubMed Web of Science ®Google Scholar
• van der Linden CM, Jansen PA, van Marum RJ, et al. An electronic system to document reasons for medication discontinuation and to flag unwanted represcriptions in geriatric patients. Drugs Aging. 2012;29(12):957–962.
   PubMed Web of Science ®Google Scholar
• Lampela P, Hartikainen S, Lavikainen P, et al. Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study. Drugs Aging. 2010;27(6):507–521.
   PubMed Web of Science ®Google Scholar
• Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008;168(17):1890–1896.
   PubMed Web of Science ®Google Scholar
• Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63(2):136–147.
   PubMed Web of Science ®Google Scholar
• Holmes HM, Sachs GA. Meaningful deprescribing in the nursing home. Ann Intern Med. 2017;167(9):671–672.
   PubMed Web of Science ®Google Scholar
• Perri M 3rd, Menon AM, Deshpande AD, et al. Adverse outcomes associated with inappropriate drug use in nursing homes [Research support, non-U.S. Gov’t]. Ann Pharmacother. 2005;39(3):405–411.
   PubMed Web of Science ®Google Scholar
• Wilson N, Hilmer S, March L, et al. Physical functioning measures and risk of falling in older people living in residential aged care facilities. Ther Adv Musculoskelet Dis. 2011;3(1):9–15.
   PubMedGoogle Scholar
• Harrison SL, Kouladjian O’Donnell L, Bradley CE, et al. Associations between the drug burden index, potentially inappropriate medications and quality of life in residential aged care. Drugs Aging. 2018;35(1):83–91.
   PubMed Web of Science ®Google Scholar
• Testad I, Auer S, Mittelman M, et al. Nursing home structure and association with agitation and use of psychotropic drugs in nursing home residents in three countries: Norway, Austria and England. Int J Geriatr Psychiatry. 2010;25(7):725–731.
   PubMed Web of Science ®Google Scholar
• Westbury J, Gee P, Ling T, et al. More action needed: psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry. 2018;53(2):136–147.
   PubMed Web of Science ®Google Scholar
• Simoni-Wastila L, Wei YJ, Luong M, et al. Quality of psychopharmacological medication use in nursing home residents. Res Social Adm Pharm. 2014;10(3):494–507.
   PubMed Web of Science ®Google Scholar
• Alldred DP, Kennedy MC, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev. 2016;2:Cd009095.
   PubMed Web of Science ®Google Scholar
• Wouters H, Scheper J, Koning H, et al. Discontinuing inappropriate medication use in nursing home residents: a cluster randomized controlled trial. Ann Intern Med. 2017;167(6):609–617.
   PubMedGoogle Scholar
• JL W, Gee P, Ling T, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Med J Aust. 2018;208(9):398–403.
   PubMed Web of Science ®Google Scholar
• Sawan M, Jeon Y-H, Chen TF. Relationship between organizational culture and the use of psychotropic medicines in nursing homes: a systematic integrative review [journal article]. Drugs Aging. 2018;35(3):189–211.
   PubMed Web of Science ®Google Scholar
• Sawan M, Jeon YH, Fois RA, et al. Exploring the link between organizational climate and the use of psychotropic medicines in nursing homes: a qualitative study. Res Social Adm Pharm. 2017;13(3):513–523.
   PubMed Web of Science ®Google Scholar
• Aerts L, Cations M, Harrison F, et al. Why deprescribing antipsychotics in older people with dementia in long-term care is not always successful: insights from the HALT study. Int J Geriatr Psychiatry. 2019;34(11):1572–1581.
   PubMed Web of Science ®Google Scholar
• Cody M, Beck C, Svarstad BL. Mental health services in nursing homes: challenges to the use of nonpharmacologic interventions in nursing homes. Psychiatr Serv. 2002;53(11):1402–1406.
   PubMed Web of Science ®Google Scholar
• Sawan M, Jeon YH, Fois RJ, et al. A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes? Int Psychogeriatr. 2016;28(10):1725–1735.
   PubMed Web of Science ®Google Scholar
• Loganathan M, Singh S, Franklin BD, et al. Interventions to optimise prescribing in care homes: systematic review. Age Ageing. 2011;40(2):150–162.
   PubMed Web of Science ®Google Scholar
• Sawan M, Kouladjian O’Donnell L, Hilmer SN. Perspectives of residential aged care facilities’ staff on the identification and recording of residents’ medication-related goals of care. Australas J Ageing. Epub ahead of print. 2019. doi: 10.1111/ajag.12714.
   PubMed Web of Science ®Google Scholar
• Hughes CM. Implementation of pharmaceutical care in nursing homes. In: Alves da Costa F, JWF VM, Alvarez-Risco A, editors. The pharmacist guide to implementing pharmaceutical care. Cham: Springer International Publishing; 2019. p. 225–233.
   Google Scholar
• Sanz-Tamargo G, Garcia-Cases S, Navarro A, et al. Adaptation of a deprescription intervention to the medication management of older people living in long-term care facilities. Expert Opin Drug Saf. 2019;18(11):1091–1098.
   PubMed Web of Science ®Google Scholar
• Inch J, Notman F, Bond CM, et al. The Care Home Independent Prescribing Pharmacist Study (CHIPPS)—a non-randomised feasibility study of independent pharmacist prescribing in care homes [journal article]. Pilot Feasibility Stud. 2019;5(1):89.
   PubMedGoogle Scholar
• Australian Government Department of Health. The National Medicines Policy; 2019 [cited2019 Sept 25]. Available from: https://www1.health.gov.au/internet/main/publishing.nsf/Content/National+Medicines+Policy-1
   Google Scholar
• Shaw J, Murphy AL, Turner JP, et al. Policies for deprescribing: an international scan of intended and unintended outcomes of limiting sedative-hypnotic use in community-dwelling older adults. Healthc Policy. 2019;14(4):39–51.
   PubMedGoogle Scholar
• Martin D, Miller AP, Quesnel-Vallee A, et al. Canada’s universal health-care system: achieving its potential. Lancet. 2018;391(10131):1718–1735.
   PubMed Web of Science ®Google Scholar
• Conference Board of Canada T. A review of pharmacy services in Canada and the health and economic evidence Ottawa. ON, Canada: Canadian Pharmacists Association; 2016.
   Google Scholar
• Martin P, Tamblyn R, Benedetti A, et al. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. JAMA. 2018;320(18):1889–1898.
   PubMed Web of Science ®Google Scholar
• SaferMedsNL. 2018 [cited 2020 Jan 02]. Available from: https://safermedsnl.ca/
   Google Scholar
• Greiver M, Dahrouge S, O’Brien P, et al. Improving care for elderly patients living with polypharmacy: protocol for a pragmatic cluster randomized trial in community-based primary care practices in Canada. Implement Sci. 2019;14(1):55.
   PubMedGoogle Scholar
• Tannenbaum C, Martin P, Tamblyn R, et al. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–898.
   PubMed Web of Science ®Google Scholar
• Turner JP, Caetano P, Tannenbaum C. Leveraging policy to reduce chronic opioid use by educating and empowering community dwelling adults: a study protocol for the TAPERING randomized controlled trial. Trials. 2019;20(1):412.
   PubMedGoogle Scholar
• Hirdes JP, Major J, Didic S, et al. Study protocol and baseline comparisons for a pan-Canadian initiative to reduce inappropriate use of antipsychotics in long-term care homes. SAGE Open. 2019;9(1):215824401983594.
   Web of Science ®Google Scholar
• National Committee for Quality Assurance. Medication Management in the Elderly (DAE/DDE). 2019 [ cited 2019 Sep 16]. https://www.ncqa.org/hedis/measures/medication-management-in-the-elderly/
   Google Scholar
• Brandt NJ, Cooke CE. Centers for medicare and medicaid services support for medication therapy management (enhanced medication therapy management): testing strategies for improving medication use among beneficiaries enrolled in medicare part D. Clin Geriatr Med. 2017;33(2):153–164.
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society. Updated AGS beers criteria(R) for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674–694.
   PubMed Web of Science ®Google Scholar
• Simonson W. Significant changes in CMS pharmacy services F-Tags for long-term care facilities. Geriatr Nurs. 2018;39(1):112–114.
   PubMed Web of Science ®Google Scholar
• Gurwitz JH, Bonner A, Berwick DM. Reducing excessive use of antipsychotic agents in nursing homes. JAMA. 2017;318(2):118–119.
   PubMed Web of Science ®Google Scholar
• Lehtonen L, Wild C, Ricciardi W, et al. Opinion on defining value in “value-based” healthcare Brussels: European commission; 2019 [cited2019 Sept 16]. Available from: https://ec.europa.eu/health/expert_panel/sites/expertpanel/files/024_valuebasedhealthcare_en.pdf
   Google Scholar
• Lavan AH, O’Mahony D, Gallagher P, et al. The effect of SENATOR (Software ENgine for the Assessment and optimisation of drug and non-drug Therapy in Older peRsons) on incident adverse drug reactions (ADRs) in an older hospital cohort - Trial Protocol. BMC Geriatr. 2019;19(1):40.
   PubMedGoogle Scholar
• Adam L, Moutzouri E, Baumgartner C, et al. Rationale and design of optimising therapy to prevent avoidable hospital admissions in multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6):e026769.
   PubMed Web of Science ®Google Scholar
• McIntosh J, Alonso A, MacLure K, et al. A case study of polypharmacy management in nine European countries: implications for change management and implementation. PLoS One. 2018;13(4):e0195232.
   PubMed Web of Science ®Google Scholar
• O’Mahony D, Gallagher P, Ryan C, et al. STOPP & START criteria: a new approach to detecting potentially inappropriate prescribing in old age. Eur Geriatr Med. 2010;1(1):45–51.
   Web of Science ®Google Scholar
• Petrovic M, Somers A, Marien S, et al. Optimization of drug use in older people: a key factor for successful aging. In: Benetos A, Robine J-M, Fernández-Ballesteros R, editors. The Cambridge handbook of successful aging. Cambridge handbooks in psychology. Cambridge: Cambridge University Press; 2019. p. 237–262.
   Google Scholar
• van der Cammen TJ, Rajkumar C, Onder G, et al. Drug cessation in complex older adults: time for action. Age Ageing. 2014;43(1):20–25.
   PubMed Web of Science ®Google Scholar
• How does Australia’s health system work?: Canberra: Australian Institute of Health and Welfare; 2016 [cited 2020 Jan 28]. Available from: https://www.aihw.gov.au/getmedia/f2ae1191-bbf2-47b6-a9d4-1b2ca65553a1/ah16-2-1-how-does-australias-health-system-work.pdf.aspx
   Google Scholar
• Roughead EE, Semple SJ, Gilbert AL. Quality use of medicines in aged-care facilities in Australia. Drugs Aging. 2003;20(9):643–653.
   PubMed Web of Science ®Google Scholar
• Australian Government Department of Health. Guidelines for medication management in residential aged care facilities: Australian Pharmaceutical Advisory Council; 2002 [updated Nov 2002; cited 2015 Mar 20]; 3rd. Available from: http://www.health.gov.au/internet/main/publishing.nsf/Content/nmp-pdf-resguide-cnt.htm
   Google Scholar
• Jokanovic N, Tan EC, van den Bosch D, et al. Clinical medication review in Australia: a systematic review. Res Social Adm Pharm. 2016;12(3):384–418.
   PubMed Web of Science ®Google Scholar
• Chen EYH, Wang KN, Sluggett JK, et al. Process, impact and outcomes of medication review in Australian residential aged care facilities: a systematic review. Australas J Ageing. 2019;38(S2):9–25.
   PubMedGoogle Scholar
• Nishtala PS, Hilmer SN, McLachlan AJ, et al. Impact of residential medication management reviews on drug burden index in aged-care homes: a retrospective analysis. Drugs Aging. 2009;26(8):677–686.
   PubMed Web of Science ®Google Scholar
• Castelino RL, Hilmer SN, Bajorek BV, et al. Drug burden index and potentially inappropriate medications in community-dwelling older people: the impact of home medicines review. Drugs Aging. 2010;27(2):135–148.
   PubMed Web of Science ®Google Scholar
• Quality Use of Medicines to Optimise Ageing in Older Australians: Recommendations for a National Strategic Action Plan to Reduce Inappropriate Polypharmacy Sydney, NSW, Australia: NHMRC Cognitive Decline Partnership Centre, University of Sydney, in Collaboration, Australian Deprescribing Network and NPS MedicineWise; 2018 [cited2020 Jan 28]. Available from: http://sydney.edu.au/medicine/cdpc/resources/quality-use-of-medicines.pdf
   Google Scholar
• Linsky A, Gellad WF, Linder JA, et al. Advancing the science of deprescribing: a novel comprehensive conceptual framework. J Am Geriatr Soc. 2019;67:2018–2022.
   PubMed Web of Science ®Google Scholar
• Deacon RM, Nielsen S, Leung S, et al. Alprazolam use and related harm among opioid substitution treatment clients - 12 months follow up after regulatory rescheduling. Int J Drug Policy. 2016;36:104–111.
   PubMed Web of Science ®Google Scholar
• Lloyd B, Dwyer J, Bugeja L, et al. Alprazolam in fatal overdose following regulatory rescheduling: a response to Deacon et al. Int J Drug Policy. 2017;39:138–139.
   PubMed Web of Science ®Google Scholar
• Australian Medicines Handbook Pty Ltd. AMH aged care companion 2019 edition. Adelaide; 2019. (Ltd AMHP, editor.).
   Google Scholar
• BMJ. Group and the royal pharmaceutical society of Great Britain. London: British National Formulary; 2019.
   Google Scholar
• Farrell B, Pottie K, Rojas-Fernandez CH, et al. Methodology for developing deprescribing guidelines: using evidence and grade to guide recommendations for deprescribing. PLoS One. 2016;11(8):e0161248.
   PubMed Web of Science ®Google Scholar